Skip to content

On this page

Lumvoa

veligrotug-vvze

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Lumvoa

Proper name

veligrotug-vvze

Licence type

351(a)

BLA number

761530

Applicant

Viridian Therapeutics, Inc.

Center

CDER

Presentations

1

First licensure

—

Presentations

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
500MG/10ML (50MG/ML)	Injection	Intravenous	Single-Dose Vial	Rx	June 26, 2026

Sources for this page

Purple Book	FDA	Licence type, presentations, reference product, exclusivity